Cravens P D, Hayashida K, Davis L S, Nanki T, Lipsky P E
The Harold C. Simmons Arthritis Research Center, Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
Scand J Immunol. 2007 Jun;65(6):514-24. doi: 10.1111/j.1365-3083.2007.01933.x.
Human antigen presenting cells (APC) found in peripheral blood are considered to be precursors that have been released from the bone marrow and are in transit to the peripheral tissues. These APC populations include myeloid dendritic cells (mDC), plasmacytoid DC (pDC) and monocytes (Mo). To assign specialized functional roles and stages of development for APCs, CD33 expressing APC subsets were examined for their capacity to respond to chemokines. Three major CD33(+) subsets including CD33(bright)CD14(bright) Mo, CD33(bright)CD14(-) CD11c(+) mDC and CD33(dim)CD14(-) pDC were present. Dendritic cells subsets and Mo expressed low levels of CC and CXC receptors, but distinctive chemokine receptor expression profiles were not observed. The percentage of cells expressing a particular chemokine receptor varied from donor to donor and over time in the same donor. Myeloid DC and Mo but not pDC migrated toward CXCL12 in a concentration dependent manner. Monocytes and pDC, but not myeloid DC, were attracted by high concentrations of CXCL10. All CD33(+) subsets migrated in a concentration dependent manner toward CCL19, but responded less robustly to CCL21. CCL20 was not chemoattractant for any population. Despite the finding that APC did not exhibit unique surface chemokine receptor expression patterns, they exhibited differential migration to CXCL12, CXCL10 and CCL21 but not to CCL20 or CCL19.
在外周血中发现的人类抗原呈递细胞(APC)被认为是已从骨髓释放并正在向外周组织转运的前体细胞。这些APC群体包括髓样树突状细胞(mDC)、浆细胞样DC(pDC)和单核细胞(Mo)。为了确定APC的特定功能作用和发育阶段,研究了表达CD33的APC亚群对趋化因子的反应能力。存在三个主要的CD33(+)亚群,包括CD33(明亮)CD14(明亮)Mo、CD33(明亮)CD14(-)CD11c(+)mDC和CD33(暗淡)CD14(-)pDC。树突状细胞亚群和Mo表达低水平的CC和CXC受体,但未观察到独特的趋化因子受体表达谱。表达特定趋化因子受体的细胞百分比因供体而异,并且在同一供体内随时间变化。髓样DC和Mo而非pDC以浓度依赖的方式向CXCL12迁移。单核细胞和pDC而非髓样DC被高浓度的CXCL10吸引。所有CD33(+)亚群均以浓度依赖的方式向CCL19迁移,但对CCL21的反应较弱。CCL20对任何群体都不是趋化剂。尽管发现APC没有表现出独特的表面趋化因子受体表达模式,但它们对CXCL12、CXCL10和CCL21表现出不同的迁移能力,而对CCL20或CCL19则没有。